Vadakke Puthiyottil, Sanudev, Arathi Edayattil, and Suprya N K. “Pathologic Response to Neoadjuvant Subcutaneous Fixed-Dose Pertuzumab–Trastuzumab (Phesgo®) and Chemotherapy in HER2-Positive Locally Advanced Breast Cancer: A Case Series and Literature Review”. Asian Pacific Journal of Cancer Care 11, no. 3 (May 2, 2026): 481-488. Accessed May 2, 2026. http://www.waocp.com/journal/index.php/apjcc/article/view/1994.